This proposal addresses the molecular basis of growth hormone action in the liver through examination of the rat Spi I (serine protease inhibitor) 2 locus. Three hypotheses will be tested. The first is that regulation of the Stat 2.1 gene is mediated by binding of Stat5 in a cooperative fashion to two sites within the GHRE. The second is that additional proteins interact with Stat5 to mediate regulation. The third is that specificity of GH regulation through the Stat5 pathway is achieved through the unique architecture of the GHRE in the Spi 2.1 gene and these Stat5-protein interactions.
Three specific aims are proposed to test these hypotheses. 1. The investigator will further define the nuclear proteins critical for GH action in the Spi 2.1 model, establishing proof that Stat5 is necessary for Spi 2.1 gene activation, examining the role of YY1 in GH action, determining the role of glucocorticoid receptor, and evaluating the role of serine phosphorylation of Stat5. 2. The investigator will examine the functional architecture of the GHRE, exploring the significance of paired GAS-like elements in the response to GH, distinguishing characteristics of DNA elements structurally related to the Spi 2.1 GHRE but not responsive to GH, and defining other elements in the Spi 2.1 promoter important in the response to GH. 3. The investigator will compare the actions of GH and IL-6 in Spi 2.1 gene expression, defining the IL-6 response element and the nuclear factors binding to Spi 2.1 in response to IL-6 with comparison to the GH response, thereby furthering understanding of the specificity of the Spi 2.1 response to GH.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
2R01DK032817-12
Application #
2466369
Study Section
Endocrinology Study Section (END)
Program Officer
Sato, Sheryl M
Project Start
1998-05-01
Project End
2003-01-31
Budget Start
1998-05-01
Budget End
1999-01-31
Support Year
12
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Minnesota Twin Cities
Department
Pediatrics
Type
Schools of Medicine
DUNS #
168559177
City
Minneapolis
State
MN
Country
United States
Zip Code
55455
Humbert, J T; Bergad, P L; Masha, O et al. (2000) Growth hormone action in hypothyroid infant rats. Pediatr Res 47:250-5
Bergad, P L; Towle, H C; Berry, S A (2000) Yin-yang 1 and glucocorticoid receptor participate in the Stat5-mediated growth hormone response of the serine protease inhibitor 2.1 gene. J Biol Chem 275:8114-20
Bergad, P L; Schwarzenberg, S J; Humbert, J T et al. (2000) Inhibition of growth hormone action in models of inflammation. Am J Physiol Cell Physiol 279:C1906-17
Bergad, P L; Towle, H C; Berry, S A (1999) Definition of a high affinity growth hormone DNA response element. Mol Cell Endocrinol 150:151-9
Berry, S A; Bergad, P L; Stolz, A M et al. (1999) Regulation of Spi 2.1 and 2.2 gene expression after turpentine inflammation: discordant responses to IL-6. Am J Physiol 276:C1374-82
Bergad, P L; Shih, H M; Towle, H C et al. (1995) Growth hormone induction of hepatic serine protease inhibitor 2.1 transcription is mediated by a Stat5-related factor binding synergistically to two gamma-activated sites. J Biol Chem 270:24903-10
Berry, S A; Bergad, P L; Whaley, C D et al. (1994) Binding of a growth hormone-inducible nuclear factor is mediated by tyrosine phosphorylation. Mol Endocrinol 8:1714-9
Berry, S A; Bergad, P L; Bundy, M V (1993) Expression of growth hormone-responsive serpin mRNAs in perinatal rat liver. Am J Physiol 264:E973-80
Berry, S A; Yoon, J B; List, J et al. (1993) Hepatic fatty acid-binding protein mRNA is regulated by growth hormone. J Am Coll Nutr 12:638-42
Schwarzenberg, S J; Yoon, J B; Seelig, S et al. (1992) Discoordinate hormonal and ontogenetic regulation of four rat serpin genes. Am J Physiol 262:C1144-8

Showing the most recent 10 out of 14 publications